$OSCR

Parkev Tatevosian, CFA on $OSCR (Sep 28, 2026)

AI summary · Parkev Tatevosian, CFA

OSCR is undervalued; fair value >$41 vs price ~$30 implies >34% upside in 12-18 months driven by growth and cost control.

BullishHe framed it in months
“3 Undervalued Healthcare Stocks Invstors Can Buy Right Now”
Parkev Tatevosian, CFAPublished Sep 28 · 2 passages

Playing via YouTube may share device and playback data and use cookies. Privacy Notice · Google Privacy Policy

Jump to any passage

2 passages

Last but not least, Oscar Health, one of the top healthcare companies in terms of integrating artificial intelligence into its operations to improve efficiency and performance.

It is one of the fastest growing healthcare companies since 2024. It has achieved a compound annual revenue growth rate of over 40%. Management anticipates compound annual revenue growth rates exceeding 20% from now until 2030.

It is controlling costs, and profits are improving as a result of this expansion in revenue and net profit.

I calculated a fair value for Oscar Health stock at over $41 per share. The current market price of the stock is just over $30. Therefore, this difference creates an upward trend for Oscar Health of more than 34% over the next twelve to eighteen months.

TickerSays